ViroQ® SARS-FluA/B-RSV – the clever test kit
Certainty of flu symptoms in just one PCR run
Coronavirus or influenza? Patients' symptoms do not provide any information about the causative pathogens. However, in order to contain the flare-up of further outbreaks of infection with SARS-CoV-2, quick and reliable test results are the most important thing that can provide a reliable answer.
Influenza A viruses can also cause widespread waves of influenza – up to continental pandemics with severe to life-threatening disease courses. Even Influenza B viruses can trigger diseases, some of which are of moderate severity. A rapid diagnosis of the corresponding virus strain facilitates the treatment of the symptoms that occur.
With ViroQ® SARS-FluA/B-RSV, we have therefore developed an innovative test kit, which detects in a single test run
- Influenza A
- Influenza B
in the sample material taken. In addition, the real-time kit indicates whether sufficient cell material for valid test results is contained in the samples taken from the throat-nasal swab.
Attention: New variant of SARS-CoV-2 from UK is covered by our ViroQ® kits.
Customized to your needs
With ViroQ® SARS-FluA/B-RSV you have great flexibility! The test kit can be combined with common RNA isolation kits and is designed for use on standard real-time cyclers. Valid results are available after 60 minutes.
"Why ViroQ® SARS-FluA/B-RSV? The influenza situation has changed considerably with Coronavirus. ViroQ® SARS-FluA/B-RSV provides rapid analysis of test swabs in just one PCR run. This helps to initiate the right treatment and reliably localise SARS-CoV-2 disease. Important laboratory resources are thus optimally used."
Swab specimen extraction correct – test result reliable
A correct nasal/pharyngeal swab is essential for a meaningful result. While blood impurities affect performance, inadequate swabs sometimes contain too little cellular material. The ViroQ® SARS-FluA/B-RSV kit rules out "false negative test results" resulting from this: In the test, the detection of a human, universally occurring gene in cells shows whether sufficient cell material is available for valid results.
- Four tests in one kit – detection of SARS-CoV-2, Influenza A/B or RS viruses
- Time saving thanks to one-step real-time PCR procedure – get your results in a good 60 minutes
- Testing of the sample quality – no false negative results
- Safe handling, ready-to-use reagents
- Low logistics costs – transport the kits uncooled
One-step real-time PCR
Our test kit is designed for the specific detection of the viral RNA gene N and the RdRP of SARS-CoV-2 as well as influenza A/B or RS viruses from throat/nasal swabs. In our test kits the RNA is converted into cDNA in a one-step PCR procedure. This cDNA is amplified in the same real-time PCR protocol.
The kit includes the following components:
|1. tube||Mastermix: transcription + amplification|
|2. tube||Reconstitution buffer for lyophilised mastermix|
|3. tube||Primer-Probe Mixture:
Colour 1: Virus gene 1 (FAM)
Colour 2: Influenza A (HEX)
Colour 3: Influenza B (CY5)
Colour 4: RSV (CFR610)
|4. tube||Primer-probe mixture:
Colour 5: Cell control (Q705) (housekeeping gene)
|5. tube||Primer-probe mixture:
Colour 5: Cell control (ATTO425) (housekeeping gene)
|6. tube||Primer-probe mixture:
Colour 5: Cell control (TAMRA) (housekeeping gene)
|7. tube||Positive Control (SARS-CoV-2-Influenza A/B-RSV Positive Control)|
We have designed our testing to focus entirely on your needs: Simple and fast! Get results in just over 60 minutes with our ready-to-use standard reagents. The one-step PCR run (incl. reverse transcription) in the real-time cycler delivers fast results. In addition, the cell material check reliably secures negative results.
More information about our rapid test:
Further information about COVID-19 and about our test kits can be found in our FAQs. Here we answer questions about workflow, health measures, test kits and the evaluation procedure.